FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
NASDAQ:AXLA
Delisted

Axcella Health Inc. Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.401
+0 (+0%)
At Close: Mar 28, 2024
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.401 $0.401 Thursday, 28th Mar 2024 AXLA stock ended at $0.401. During the day the stock fluctuated 0% from a day low at $0.401 to a day high of $0.401.
90 days $0.360 $0.510
52 weeks $0.340 $41.25

Historical Axcella Health Inc. prices

Date Open High Low Close Volume
Mar 28, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 27, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 26, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 25, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 22, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 21, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 20, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 19, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 18, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 15, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 14, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 13, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 12, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 11, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 08, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 07, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 06, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 05, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 04, 2024 $0.401 $0.401 $0.401 $0.401 0
Mar 01, 2024 $0.401 $0.401 $0.401 $0.401 0
Feb 29, 2024 $0.401 $0.401 $0.401 $0.401 0
Feb 28, 2024 $0.401 $0.401 $0.401 $0.401 0
Feb 27, 2024 $0.401 $0.401 $0.401 $0.401 0
Feb 26, 2024 $0.401 $0.401 $0.401 $0.401 0
Feb 23, 2024 $0.401 $0.401 $0.401 $0.401 0
Click to get the best stock tips daily for free!

About Axcella Health Inc.

Axcella Health. Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well a... AXLA Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 1.95% $11.28
MLI Apr 19 11.07% $52.28
LPLA Apr 19 4.31% $262.59
DOOR Apr 18 0.90% $131.39
PFLT Apr 18 1.78% $11.25
LNG Apr 17 3.12% $156.81
FCN Apr 16 2.83% $207.62
ELV Apr 16 5.33% $506.97
AKR Apr 05 6.47% $16.53
ITCI Apr 05 5.64% $68.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT